Oculis Holding AG (OCS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec6

Oculis Holding AG Attending Ophthalmology Conference to Introduce Innovative Late-Stage Pipeline

14:03

Nov11

Oculis Holding AG released FY2025 Q3 earnings on November 10 After-Market (EST), actual revenue USD 0 (forecast USD 230.15 K), actual EPS USD 0 (forecast USD -0.5233)

04:00

Oculis Holding AG released FY2025 9 Months Earnings on November 10, 2025 (EST) with actual revenue of USD 954.32K and EPS of USD -1.7909

04:00

Nov5

Oculis Holding AG Participates in ICR Healthcare Conference to Discuss Late-Stage Pipeline

09:00

Nov3

Oculis Holding AG to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast Revenue USD 229.13K, EPS USD -0.521

00:19

Oct30

Oculis Holding AG Raises $110 Million through Stock Sale

08:37

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 304.71 K, Net Income -21.14 M, EPS -0.4036

Aug21

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 326.33 K, Net Income -31.73 M, EPS -0.6067

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 323.28 K, Net Income -37.67 M, EPS -0.7805

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change